SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment

Overview of attention for article published in BMC Medicine, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 21,243 followers.

RT @BMCMedicine: Oncolytic virus therapy in combination with anti-SIRPα antibodies can protect against tumours. Read the interesting repor…

Reply Repost Favourite

RT @WenZhang8228: Happy to share our last work. @BMCMedicine

Reply Repost Favourite

Happy to share our last work. @BMCMedicine

Reply Repost Favourite

🛡️ The SIRPα antibody combined with oncolytic virus OH2 protects against tumors by activating #InnateImmunity and reprogramming the tumor immune microenvironment, reports a team from the Chinese Academy of Medical Sciences. https://t.co/XYyH1HXonT https:

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.